News > World CDx Boston 2015


World CDx Boston 2015

The 6th Annual World CDx Boston Summit continues to guide drug, diagnostic and technology developers all the way from early clinical development and translational biomarker validation to market launch of drug-CDx combinations.


OWL Metabolomics will attend the World CDx Boston Congress and present the latest news about CDx in Non-Alcoholic Steatohepatitis.


Place:  Boston, MA.


Attendee: Angel Santos.


Poster title: Development of A Non-Invasive Companion Diagnostic Program for Non-Alcoholic Steatohepatitis.


Authors: Pablo Ortiz, Cristina Alonso, Angel Santos.

OWL is a trading name of
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
+34 94 431 85 40

With this web OWL intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a
qualified physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 11/29/2021

With the collaboration of: